The Europe Biochips Market would witness market growth of 10.8% CAGR during the forecast period (2019-2025).
Biochip includes a transponder and a reader. Transponders come in two types, passive transponders, and active transponders. The passive transponder has no power or battery at all, while it is passive only when the user activates it by providing it with a small electrical charge. This transponder comprises of four components, including antenna coil, a microchip, and a tuning capacitor. The reader consists of an "exciter" coil, and through radio signaling, it creates an electromagnetic field. It provides the energy needed to enable the biochip.
For a proteome-wide assessment, this feature of microarrays is essential. Biomarker and drug discovery are commonly used in proteomics. In addition, the surge in the requirement for personalized disease medicine helps the industry grow. The biochip market is being largely influenced by factors such as increased use of biochips in the treatment and diagnosis of cancer and demand for personally tailored medicine, and rapid technological progress.
Based on Product, the market is segmented into DNA Chip, Protein Chip, Lab-on-Chip and Other Products. Based on Application, the market is segmented into Drug Discovery and Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Fluidigm Corporation, Horiba Ltd., PerkinElmer, Inc., OriGene Technologies, Inc., Dynamic Biosensors GmbH, Illumina, Inc., Qiagen N.V., Bio-Rad Laboratories, Inc., Randox Laboratories Limited, Thermo Fisher Scientific, Inc.
Market Segmentation:
ByProduct
By Application
By End User
By Country
Companies Profiled
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.